Image of an retail interior and an open sign with text overly reading Ohio Medical Marijuana Control Program at Two Years: Evaluating Satisfaction and Perception  


A new report from the Drug Enforcement and Policy Center (DEPC) indicates continued dissatisfaction with the Ohio Medical Marijuana Control Program (OMMCP), primarily based on pricing. The report builds on a previous, first-of-its-kind survey conducted in 2019 by DEPC and Harm Reduction Ohio.

This research aims to fill in a critical gap in our understanding of the OMMCP. With future marijuana reforms on the horizon, the perceived effectiveness and success of the current system among patients and potential patients may shape the long-term future of the program.


Selected Findings

  • 61.6% of respondents reported being “extremely” or “somewhat dissatisfied” with the OMMCP. This is a slight decrease from 67% in 2019. However, the degree of dissatisfaction decreased significantly. 30.2% reported extreme dissatisfaction in this year’s survey compared with 48% in 2019.
  • Two main reasons cited for not using medical marijuana: cost and a fear of losing employment.
  • 51.5% of respondents with a qualifying condition reported that they currently use marijuana.
  • 84.2% of respondents indicated preference for purchasing marijuana from a legal dispensary if marijuana was made fully legal and product was similarly priced to the unregulated market.
  • 52.8% of people who reported a qualifying condition and to be currently using marijuana have received a doctor’s recommendation under the OMMCP.

Read and download the full report on SSRN.


Email Holly Griffin, Public Engagement Specialist, Drug Enforcement and Policy Center, at griffin.235@osu.edu.